Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism.

[1]  R. Henry,et al.  Role of Glycogen Synthase Kinase-3α in Insulin Action in Cultured Human Skeletal Muscle Cells , 2007 .

[2]  B. Doble,et al.  Functional redundancy of GSK-3α and GSK-3β in wnt/β-catenin signaling shown by using an allelic series of embryonic stem cell lines , 2007 .

[3]  Marina Gertsenstein,et al.  Developmental and adult phenotyping directly from mutant embryonic stem cells , 2007, Proceedings of the National Academy of Sciences.

[4]  H. Eldar-Finkelman,et al.  Long-Term Treatment with Novel Glycogen Synthase Kinase-3 Inhibitor Improves Glucose Homeostasis in ob/ob Mice: Molecular Characterization in Liver and Muscle , 2006, Journal of Pharmacology and Experimental Therapeutics.

[5]  A. Morris,et al.  A novel regulation of IRS1 (insulin receptor substrate-1) expression following short term insulin administration. , 2005, The Biochemical journal.

[6]  A. Depaoli-Roach,et al.  Glucose metabolism in mice lacking muscle glycogen synthase. , 2005, Diabetes.

[7]  H. Deng,et al.  Simple and efficient production of mice derived from embryonic stem cells aggregated with tetraploid embryos , 2005, Molecular reproduction and development.

[8]  E. Henriksen,et al.  Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle. , 2005, American journal of physiology. Endocrinology and metabolism.

[9]  D. Alessi,et al.  Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis , 2005, The EMBO journal.

[10]  C. Sutherland,et al.  Constitutive Activation of GSK3 Down-regulates Glycogen Synthase Abundance and Glycogen Deposition in Rat Skeletal Muscle Cells* , 2005, Journal of Biological Chemistry.

[11]  H. Eldar-Finkelman,et al.  Serine 332 Phosphorylation of Insulin Receptor Substrate-1 by Glycogen Synthase Kinase-3 Attenuates Insulin Signaling* , 2005, Journal of Biological Chemistry.

[12]  J. Holder,et al.  Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter. , 2004, Metabolism: clinical and experimental.

[13]  A. Vaag,et al.  Reduced glycogen synthase activity in skeletal muscle from obese patients with and without Type 2 (non-insulin-dependent) diabetes mellitus , 1991, Diabetologia.

[14]  M. Coghlan,et al.  Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase. , 2003, European journal of biochemistry.

[15]  Kirk W. Johnson,et al.  Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats. , 2003, American journal of physiology. Endocrinology and metabolism.

[16]  P. Morris,et al.  Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects. , 2003, American journal of physiology. Endocrinology and metabolism.

[17]  H. Eldar-Finkelman,et al.  The role of glycogen synthase kinase-3 in insulin resistance and Type 2 diabetes , 2002, Expert opinion on therapeutic targets.

[18]  Kirk W. Johnson,et al.  Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. , 2002, Diabetes.

[19]  M. White,et al.  IRS proteins and the common path to diabetes. , 2002, American journal of physiology. Endocrinology and metabolism.

[20]  P. Roach,et al.  Glycogen and its metabolism. , 2002, Current molecular medicine.

[21]  G. Browne,et al.  The level of the glycogen targetting regulatory subunit R5 of protein phosphatase 1 is decreased in the livers of insulin-dependent diabetic rats and starved rats. , 2001, The Biochemical journal.

[22]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[23]  P. Cohen,et al.  A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. , 2001, Molecular Cell.

[24]  J W Yates,et al.  Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. , 2000, Chemistry & biology.

[25]  J. Woodgett,et al.  Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation , 2000, Nature.

[26]  R. Garofalo,et al.  Inhibition of Glycogen-synthase Kinase 3 Stimulates Glycogen Synthase and Glucose Transport by Distinct Mechanisms in 3T3-L1 Adipocytes* , 2000, The Journal of Biological Chemistry.

[27]  S. Mudaliar,et al.  Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. , 2000, Diabetes.

[28]  N. Raben,et al.  Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  E. Krebs,et al.  Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice. , 1999, Diabetes.

[30]  J. Halaas,et al.  Leptin and the regulation of body weight in mammals , 1998, Nature.

[31]  C. Kahn,et al.  Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. , 1997, The Journal of clinical investigation.

[32]  E. Krebs,et al.  Expression and characterization of glycogen synthase kinase-3 mutants and their effect on glycogen synthase activity in intact cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. Mudaliar,et al.  Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms. , 1996, The Journal of clinical investigation.

[34]  G. Shulman,et al.  13C-nuclear magnetic resonance spectroscopy studies of hepatic glucose metabolism in normal subjects and subjects with insulin-dependent diabetes mellitus. , 1994, The Journal of clinical investigation.

[35]  G. Shulman,et al.  Quantitative comparison of pathways of hepatic glycogen repletion in fed and fasted humans. , 1990, The American journal of physiology.

[36]  J. Woodgett,et al.  Molecular cloning and expression of glycogen synthase kinase‐3/factor A. , 1990, The EMBO journal.

[37]  R G Shulman,et al.  Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. , 1990, The New England journal of medicine.

[38]  P. Cohen,et al.  Glycogen synthase kinase-3 from rabbit skeletal muscle. , 2005, Methods in enzymology.

[39]  R. J. Bondar,et al.  Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum. , 1974, Clinical chemistry.

[40]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.